State Street Corp Standard Biotools Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Standard Biotools Inc. stock. As of the latest transaction made, State Street Corp holds 5,495,136 shares of LAB stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,495,136

Previous 4,337,152 26.7%

Holding current value

$10.1 Million

Previous $7.68 Million 38.16%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.42 - $2.35 $1.64 Million - $2.72 Million	1,157,984 Added 26.7%	5,495,136 $10.6 Million
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $4.94 Million - $8.75 Million	2,995,795 Added 223.34%	4,337,152 $7.68 Million
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $1.95 Million - $2.9 Million	1,042,720 Added 349.16%	1,341,357 $3.64 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $30,369 - $52,143	19,100 Added 6.83%	298,637 $659,000
Q1 2023 May 15, 2023	SELL	$1.3 - $2.24 $2,860 - $4,928	-2,200 Reduced 0.78%	279,537 $545,000
Q3 2022 Nov 15, 2022	SELL	$1.1 - $2.06 $58,410 - $109,386	-53,100 Reduced 15.86%	281,737 $310,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.99 $1.93 Million - $4.8 Million	-1,203,269 Reduced 78.23%	334,837 $536,000
Q1 2022 May 16, 2022	BUY	$2.8 - $3.96 $198,926 - $281,338	71,045 Added 4.84%	1,538,106 $5.52 Million
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $53,647 - $90,595	14,779 Added 1.02%	1,467,061 $5.75 Million
Q3 2021 Nov 15, 2021	BUY	$5.5 - $7.41 $31,295 - $42,162	5,690 Added 0.39%	1,452,282 $9.57 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $751,427 - $1.1 Million	172,742 Added 13.56%	1,446,592 $8.91 Million
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $161,039 - $289,789	-40,873 Reduced 3.11%	1,273,850 $5.76 Million
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $371,319 - $589,341	68,132 Added 5.47%	1,314,723 $7.89 Million
Q3 2020 Nov 10, 2020	SELL	$4.34 - $11.43 $245,648 - $646,949	-56,601 Reduced 4.34%	1,246,591 $9.26 Million
Q2 2020 Aug 14, 2020	SELL	$1.85 - $5.29 $154,948 - $443,069	-83,756 Reduced 6.04%	1,303,192 $5.23 Million
Q1 2020 May 11, 2020	BUY	$1.24 - $4.35 $1.72 Million - $6.03 Million	1,386,948 New	1,386,948 $3.52 Million

Others Institutions Holding LAB

# of Institutions

142

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Standard Biotools Inc. Transaction History